Open Accessibility Menu

Endocrinology

About Us

The physicians and health care professionals in The GW Medical Faculty Associates Division of Endocrinology & Metabolism excel at providing comprehensive evaluation, diagnosis, treatment and management of endocrine disorders. These include diabetes, thyroid diseases, bone and mineral disorders, adrenal and pituitary diseases, endocrine tumors and reproductive disorders.

In addition to providing superior patient care, our physicians conduct clinical research in endocrine disorders and offer the most effective, advanced treatment options and technologies.

Conveniently Located

Clinical Trials

  • Role of Linagliptin in improving renal failure by improving CD34+ stem cell number, function and gene expression in renal function impaired type 2 diabetes patients.
    We are looking to see if Tradjenta, an FDA Approved Type 2 Diabetes medication, can help improve kidney function and cardiovascular health. We are looking for patients aged 40-70 years with Type 2 Diabetes who are taking Metformin, Insulin, or BOTH Insulin and Metformin. Your HbA1C should be between 6.5 – 10 %.
  • Role of Canagliflozin on gene expression and function of CD34+ endothelial progenitor cells in patients with type 2 diabetes and mild chronic kidney disease (Stages 1-2, CKD)
    We are looking to see if Invokana, an FDA Approved Type 2 Diabetes medication, can help improve kidney function and cardiovascular health. We are looking for patients aged 40-70 years with Type 2 Diabetes who are taking Metformin (1000-2000mg). Your HbA1C should be between 7 – 10 %.